๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The use of prostate-specific antigen kinetics to stratify risk in prostate cancer

โœ Scribed by Joseph Presti

Publisher
Springer
Year
2008
Tongue
English
Weight
129 KB
Volume
9
Category
Article
ISSN
1527-2737

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Prostate-specific antigen in screening o
Prostate-specific antigen in screening of prostate cancer
โœ Dr. T. Ming Chu ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 467 KB ๐Ÿ‘ 1 views

Prostate-specific antigen (PSA) is a wellcharacterized human prostate-specific glycoprotein. PSA has been shown to be the most effective immunohistologic marker for prostate cancer, as well as the most useful serologic test in staging and monitoring prostate cancer and in early detection of recurren

The use of prostate specific antigen den
The use of prostate specific antigen density to improve the sensitivity of prostate specific antigen in detecting prostate carcinoma
โœ Paul R. Bretton; William P. Evans; James D. Borden; Ronald D. Castellanos ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 442 KB ๐Ÿ‘ 2 views

Background. Prostate specific antigen (PSA) is useful as a tumor marker for monitoring patients with prostate cancer after definitive therapy. Limitations have been noted when PSA was used for the early detection of prostate cancer. The use of prostate specific antigen density [PSAD = PSA (ng/ml)/pr

The fall and rise of prostate-specific a
The fall and rise of prostate-specific antigen: Kinetics of serum prostate-specific antigen levels after radiation therapy for prostate cancer
โœ Gunar K. Zagars; Alan Pollack ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 890 KB

Background. The serum kinetics of prostate-specific antigen (PSA) after radiation therapy for prostate cancer are not well characterized, and the potential prognostic significance of serum half-lives and of serum doubling times is unclear. This study was designed to address those issues. Methods. O